| One of the biggest issues which will arise during GMP | | | | needs to be adhered to ensure the safety of both |
| auditing inspections is that of active pharmaceutical | | | | the products themselves and the way in which they |
| ingredients (APIs) as this is the component which will | | | | are manufactured - and this is something that these |
| be the most central to the creation of pharmaceutical | | | | inspections help to facilitate. |
| goods. GMP auditing inspections will go some way to | | | | It is something that will be carried out sporadically |
| ensuring that APIs are safe and manufactured in the | | | | each year and pharmaceutical manufacturing plants |
| right way. | | | | will need to make sure their facilities are up to |
| GMP auditing inspections are, of course, carried out | | | | scratch and that good manufacturing practices are |
| with the intention of making sure that good | | | | being adhered to. More and more companies are, as |
| manufacturing practices are adhered to during the | | | | a result of the need to get their products to the |
| creation of pharmaceutical products. One of the most | | | | market safely and speedily, turning to the expertise |
| important issues that will need to be taken into | | | | of pharmaceutical consultancy firms to guide them |
| account is that of the active ingredients used | | | | through the ins and outs of GMP compliance and |
| because it is these which are claiming to provide the | | | | regulations. |
| results that the products are being purchased for. | | | | The pharmaceutical industry has to be heavily |
| GMP Auditing - Active Ingredients | | | | regulated for all sorts of reasons and making sure |
| Under legislation passed by the European Union, it is | | | | that dangerous products don't reach the marketplace |
| essential that the active ingredients utilised in | | | | is chief amongst these. A set of good manufacturing |
| pharmaceutical products are manufactured in such a | | | | practices is one of the most instrumental means of |
| manner that they will pass GMP auditing inspections | | | | ensuring that products are crafted as safely as |
| and are as safe as possible. It is clearly apparent that | | | | possible and carrying out GMP auditing inspections on |
| it is dangerous for pharmaceutical goods to be | | | | a routine basis will help to guarantee that these |
| produced without a set criteria of legislation which | | | | criteria are being followed as a matter of course. |